logo
Select company
Select metric
$ 9.93MCore Assets
VS
Market
11
Sector
26
Industry
15
History
55
$ 4.3Close
$ 1.96 - $ 4.3 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 50.52M$ 25.99M$ 9.93M$ 14.6M
3/31/2025$ 60.36M$ 32.73M$ 13.03M$ 14.6M
12/31/2024$ 35.08M$ 10.34M$ 10.14M$ 14.61M
9/30/2024$ 70.22M$ 5.06M$ 8.62M$ 56.53M
6/30/2024$ 74.72M$ 10.96M$ 7.21M$ 56.55M
3/31/2024$ 70.97M$ 7.28M$ 7.12M$ 56.57M
12/31/2023$ 74.89M$ 11.13M$ 7.17M$ 56.59M
9/30/2023$ 81.59M$ 15.48M$ 9.49M$ 56.62M
6/30/2023$ 87.54M$ 19.07M$ 11.83M$ 56.64M
3/31/2023$ 82.8M$ 13.5M$ 12.64M$ 56.66M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 23.27M.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average Core Assets has been $ 12.92M.
  • The median Core Assets for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was $ 12.24M
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest Core Assets over the past 5 years at $ 24.08M.
  • The lowest Core Assets recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe $ 7.12M

INSIGHT MOLECULAR DIAGNOSTICS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
VNRX : VOLITIONRX LTD $ 6.14MARMP : ARMATA PHARMACEUTICALS INC $ 67.58MCBUS : CIBUS INC $ 44.63MPYXS : PYXIS ONCOLOGY INC $ 108.52MNTRB : NUTRIBAND INC $ 1.23MPRPH : PROPHASE LABS INC $ 28.18MLUCD : LUCID DIAGNOSTICS INC $ 7.02MPSTV : PLUS THERAPEUTICS INC $ 7.34MBNBX : APPLIED DNA SCIENCES INC $ 1.76MALGS : ALIGOS THERAPEUTICS INC $ 115.94M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for INSIGHT MOLECULAR DIAGNOSTICS INC is calculated as follows: Assets [ $ 57.78M ] - Intangibles [ $ 24.22M ] - CashnEq [ $ 10.29M ]
(=) Core Assets [ $ 23.27M ]

IMDX - Core Assets, Last 5 years

$ 7.12M

Minimum

Mar 31, 2024

$ 24.08M

Maximum

Dec 31, 2020

$ 12.92M

Average

$ 12.24M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 799.74M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.38B
average$ 799.74M
median$ 287.51M
std$ 1.05B